Evidence map›Paper›PMID 36499677›Full record

ArticleInternational journal of molecular sciences2022

Mechanism of Synergy between Piceatannol and Ciprofloxacin against

Mengyan Shi, Yubin Bai, Yanhua Qiu, Xinxin Zhang, Zikang Zeng, Lingling Chen, Fusheng Cheng, Jiyu Zhang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Piceatannol: a renaissance in antibacterial innovation unveiling synergistic potency and virulence disruption against serious pathogens.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  8. WildMolecules (Basel, Switzerland) · 2024
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mengyan ShiKey Laboratory of New Animal Drug Project of Gansu Province, Lanzhou 730050, China.ORCID 0000-0001-7029-9341
Yubin BaiKey Laboratory of New Animal Drug Project of Gansu Province, Lanzhou 730050, China.ORCID 0000-0002-6855-8524
Yanhua QiuKey Laboratory of New Animal Drug Project of Gansu Province, Lanzhou 730050, China.
Xinxin ZhangKey Laboratory of New Animal Drug Project of Gansu Province, Lanzhou 730050, China.
Zikang ZengKey Laboratory of New Animal Drug Project of Gansu Province, Lanzhou 730050, China.
Lingling ChenKey Laboratory of New Animal Drug Project of Gansu Province, Lanzhou 730050, China.
Fusheng ChengKey Laboratory of New Animal Drug Project of Gansu Province, Lanzhou 730050, China.
Jiyu ZhangKey Laboratory of New Animal Drug Project of Gansu Province, Lanzhou 730050, China.
Lanzhou Institute of Husbandry and Pharmaceutical Sciences · CN

Funding

the earmarked fund for CARS CARS-37the research on the Innovation Project of Chinese Academy of Agricultural Sciences 25-LZIHPS-05
6 · The paper itself

Abstract

Piceatannol (PIC) is a natural stilbene extracted from grape skins that exhibits biological activities such as antibacterial, antitumor, and antioxidant activities. The present study was carried out to further investigate the effect of PIC on the antibacterial activity of different antibiotics and to reveal the antibacterial mechanism of PIC. We found that PIC had an inhibitory effect against

Indexed as

Methicillin-Resistant Staphylococcus aureusStilbenesAnimalsAnti-Bacterial AgentsBacteriaCiprofloxacinDrug SynergismMammalsMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsCiprofloxacinStilbenesciprofloxacinpiceatannolproton motive forceS. aureussynergy

Identifiers

PMID36499677
PMCPMC9740032
OpenAlexW4310736971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.